SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 28.1 EUR 1.59% Market Closed
Market Cap: 4.2B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

SCHOTT Pharma AG & Co KgaA
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCHOTT Pharma AG & Co KgaA
Gross Profit Peer Comparison

Comparables:
E
EVT
GXI

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Gross Profit
€316.5m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Evotec SE
XETRA:EVT
Gross Profit
€126m
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
15%
Gerresheimer AG
XETRA:GXI
Gross Profit
€587.4m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
5%

See Also

What is SCHOTT Pharma AG & Co KgaA's Gross Profit?
Gross Profit
316.5m EUR

Based on the financial report for Sep 30, 2023, SCHOTT Pharma AG & Co KgaA's Gross Profit amounts to 316.5m EUR.

What is SCHOTT Pharma AG & Co KgaA's Gross Profit growth rate?
Gross Profit CAGR 3Y
17%

Over the last year, the Gross Profit growth was 7%. The average annual Gross Profit growth rates for SCHOTT Pharma AG & Co KgaA have been 17% over the past three years .

Back to Top